Netherlands Gives Funding Nod To CGRP Inhibitors For Chronic Migraines
Executive Summary
The Dutch health technology appraisal body, ZIN, said Novartis’ Aimovig should be reimbursed for the treatment of chronic migraine after initially advising against it.